Fischer Medical (FISCHER) | Financial Analysis & Statements
Fischer Medical Ventures Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
1.0B
Gross Profit
509.3M
50.38%
Operating Income
207.9M
20.57%
Net Income
192.3M
19.03%
EPS (Diluted)
₹0.29
Balance Sheet Metrics
Total Assets
4.6B
Total Liabilities
1.2B
Shareholders Equity
3.4B
Debt to Equity
0.35
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Fischer Medical Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.1B | 209.8M | 1.8M | 0 | 1.6M |
| Cost of Goods Sold | 915.9M | 164.5M | 0 | - | 0 |
| Gross Profit | 191.1M | 45.3M | 1.8M | - | 1.6M |
| Gross Margin % | 17.3% | 21.6% | 100.0% | 0.0% | 100.0% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 53.6M | 5.8M | 367.0K | 230.0K | 91.0K |
| Other Operating Expenses | 55.5M | 16.2M | 576.0K | 615.0K | 715.0K |
| Total Operating Expenses | 109.1M | 22.0M | 943.0K | 845.0K | 806.0K |
| Operating Income | 30.6M | 16.5M | 153.0K | -1.9M | -176.0K |
| Operating Margin % | 2.8% | 7.9% | 8.5% | 0.0% | -10.7% |
| Non-Operating Items | |||||
| Interest Income | 9.3M | 5.0M | 0 | - | - |
| Interest Expense | 4.0M | 676.0K | 165.0K | 87.0K | 180.0K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 22.2M | 21.1M | -13.0K | -2.0M | -356.0K |
| Income Tax | 10.1M | 2.7M | 352.0K | 352.0K | -1.8M |
| Effective Tax Rate % | 45.7% | 12.9% | 0.0% | 0.0% | 0.0% |
| Net Income | 12.1M | 18.4M | -365.0K | -2.3M | 1.4M |
| Net Margin % | 1.1% | 8.8% | -20.3% | 0.0% | 85.2% |
| Key Metrics | |||||
| EBITDA | 53.5M | 23.4M | 152.0K | -1.9M | -176.0K |
| EPS (Basic) | ₹0.01 | ₹1.65 | ₹-2.12 | ₹-13.52 | ₹8.18 |
| EPS (Diluted) | ₹0.01 | ₹1.08 | ₹-2.12 | ₹-13.52 | ₹8.18 |
| Basic Shares Outstanding | 1452090000 | 11124000 | 172000 | 172000 | 172000 |
| Diluted Shares Outstanding | 1452090000 | 11124000 | 172000 | 172000 | 172000 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Fischer Medical Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 1.0B | 9.5M | 358.0K | 156.0K | 449.0K |
| Short-term Investments | 1.5B | 370.0M | 50.0K | 50.0K | 50.0K |
| Accounts Receivable | 760.7M | 228.7M | 1.7M | 0 | - |
| Inventory | 91.6M | 44.8M | 0 | - | - |
| Other Current Assets | 1.1M | 20.6M | -1.0K | 287.0K | 275.0K |
| Total Current Assets | 3.7B | 704.1M | 2.5M | 493.0K | 774.0K |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 89.0M | 60.6M | - | - | - |
| Goodwill | 105.5M | 44.3M | 0 | - | - |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 6.2M | - | - | - | - |
| Total Non-Current Assets | 920.8M | 159.2M | 1.1M | 1.4M | 1.8M |
| Total Assets | 4.6B | 863.2M | 3.5M | 1.9M | 2.5M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 206.5M | 21.6M | 141.0K | 68.0K | 35.0K |
| Short-term Debt | 479.1M | 4.3M | 0 | 3.9M | 0 |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 116.6M | 2.0M | -1.0K | -1.0K | 31.0K |
| Total Current Liabilities | 1.0B | 38.3M | 478.0K | 4.2M | 177.0K |
| Non-Current Liabilities | |||||
| Long-term Debt | 172.1M | 12.5M | 5.7M | 0 | 2.3M |
| Deferred Tax Liabilities | 3.9M | 1.2M | 0 | - | - |
| Other Non-Current Liabilities | - | 1.0K | - | - | - |
| Total Non-Current Liabilities | 176.8M | 13.8M | 5.7M | 0 | 2.3M |
| Total Liabilities | 1.2B | 52.1M | 6.2M | 4.2M | 2.5M |
| Equity | |||||
| Common Stock | 638.0M | 535.0M | 1.7M | 1.7M | 1.7M |
| Retained Earnings | 29.0M | 12.5M | -5.9M | -5.5M | -3.2M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 3.4B | 811.1M | -2.7M | -2.3M | 31.0K |
| Key Metrics | |||||
| Total Debt | 651.2M | 16.8M | 5.7M | 3.9M | 2.3M |
| Working Capital | 2.6B | 665.7M | 2.0M | -3.7M | 597.0K |
Balance Sheet Composition
Fischer Medical Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 22.2M | 21.1M | -13.0K | -2.0M | -356.0K |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -1.0B | -196.0M | -1.7M | 85.0K | -149.0K |
| Operating Cash Flow | -1.0B | -174.5M | -1.5M | -1.8M | -325.0K |
| Investing Activities | |||||
| Capital Expenditures | -59.9M | -3.0M | 0 | 0 | - |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -1.2B | -309.0M | 0 | 0 | - |
| Investment Sales | - | - | 0 | 0 | - |
| Investing Cash Flow | -1.3B | -312.0M | 0 | 0 | - |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | 1.7M | 1.5M | 0 |
| Debt Repayment | - | - | - | - | - |
| Financing Cash Flow | 2.6B | 382.8M | 1.7M | 1.5M | -14.0K |
| Free Cash Flow | -927.3M | -78.9M | -1.5M | -1.8M | -573.0K |
| Net Change in Cash | 281.3M | -103.7M | 126.0K | -326.0K | -339.0K |
Cash Flow Trend
Fischer Medical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
63.39
Price to Book
6.72
Price to Sales
9.41
PEG Ratio
0.13
Profitability Ratios
Profit Margin
15.17%
Operating Margin
20.57%
Return on Equity
0.36%
Return on Assets
0.26%
Financial Health
Current Ratio
3.59
Debt to Equity
10.26
Beta
-0.03
Per Share Data
EPS (TTM)
₹0.59
Book Value per Share
₹5.57
Revenue per Share
₹2.78
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| FISCHER | 24.4B | 63.39 | 6.72 | 0.36% | 15.17% | 10.26 |
| HSIL Limited | 53.7B | 18.70 | - | 1,493.74% | 72.43% | 89.90 |
| Universus Photo | 4.5B | 3.27 | 0.52 | 9.95% | 28.87% | 0.00 |
| Nureca | 2.7B | 24.00 | 1.54 | 0.44% | 7.43% | 2.71 |
| Choksi Imaging | 959.5M | 18.56 | 2.45 | 8.40% | 10.42% | 7.77 |
| Maestros Electronics | 759.3M | 12.88 | 2.03 | 12.54% | 16.68% | 7.95 |
Financial data is updated regularly. All figures are in the company's reporting currency.




